Stock EPRX EUPRAXIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Delayed Toronto S.E.
Other stock markets
 07:07:31 03/06/2024 pm IST 		5-day change 1st Jan Change
3.74 CAD +2.47% Intraday chart for Eupraxia Pharmaceuticals Inc. -2.09% -30.35%
23/05 Eupraxia Pharmaceuticals Expanding RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT
23/05 Eupraxia Pharmaceuticals Inc. Brief: Announcing Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
EUPRAXIA PHARMACEUTICALS INC.
Other Biotechnology & Medical Research
+2.47%-2.09%-30.35%-45.80% - 95.3M
Neutral
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. EPRX Stock
  4. Charts Eupraxia Pharmaceuticals Inc.
  5. Comparison Chart